Susquehanna Fundamental Investments’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-37,956
| Closed | -$24.7K | – | 990 |
|
|
2025
Q1 | $24.7K | Sell |
37,956
-49,854
| -57% | -$32.4K | ﹤0.01% | 1050 |
|
|
2024
Q4 | $162K | Buy |
+87,810
| New | +$162K | ﹤0.01% | 1021 |
|
|
2024
Q2 | $660K | Buy |
225,367
+98,908
| +78% | +$290K | 0.02% | 632 |
|
|
2024
Q1 | $714K | Buy |
+126,459
| New | +$714K | 0.03% | 406 |
|
|
2023
Q4 | – | Sell |
-71,113
| Closed | -$247K | – | 302 |
|
|
2023
Q3 | $247K | Sell |
71,113
-1,872
| -3% | -$6.5K | 0.02% | 309 |
|
|
2023
Q2 | $339K | Hold |
72,985
| – | – | 0.01% | 498 |
|
|
2023
Q1 | $337K | Sell |
72,985
-4,079
| -5% | -$18.8K | 0.01% | 764 |
|
|
2022
Q4 | $623K | Buy |
+77,064
| New | +$623K | 0.01% | 798 |
|
|
2022
Q1 | – | Sell |
-17,988
| Closed | -$268K | – | 1684 |
|
|
2021
Q4 | $268K | Sell |
17,988
-19,247
| -52% | -$287K | 0.01% | 1152 |
|
|
2021
Q3 | $703K | Sell |
37,235
-10,951
| -23% | -$207K | 0.01% | 1043 |
|
|
2021
Q2 | $896K | Sell |
48,186
-2,763
| -5% | -$51.4K | 0.02% | 894 |
|
|
2021
Q1 | $1.16M | Sell |
50,949
-12,697
| -20% | -$289K | 0.02% | 829 |
|
|
2020
Q4 | $1.38M | Buy |
63,646
+21,516
| +51% | +$467K | 0.03% | 746 |
|
|
2020
Q3 | $423K | Buy |
+42,130
| New | +$423K | 0.01% | 940 |
|